Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Westphal Christoph H
Relationship:   10% Owner
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   6,222,903    

Indirect Shares

   9,212,891      
Direct Value   $9,375,314    

Indirect Value

   $367,520,825      
Total Shares   15,435,794      
Total Value   $376,896,139      


Verastem, Inc. $6,239,801 Tempest Therapeutics, Inc $744,043 Salarius Pharmaceuticals, Inc $2,391,470 Tscan Therapeutics, Inc. $0 Verastem, Inc. $6,239,801 Tempest Therapeutics, Inc $744,043 Salarius Pharmaceuticals, Inc $2,391,470 Tscan Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA Director 2004-06-25 0 2004-06-25 76,648    Premium*  
            Alnylam Pharmaceuticals Inc ALNY Director, 10% Owner 2004-05-27 0 2004-06-03 2,409,970    Premium*  
            Verastem, Inc. VSTM Executive Chairman, Di... 2015-06-30 665,224 2015-06-30 1,500,063    Premium*  
            Tempest Therapeutics, Inc TPST Director, 10% Owner 2014-03-07 701,927 2014-03-07 3,825,421    Premium*  
            Salarius Pharmaceuticals, Inc SLRX 10% Owner 2018-10-16 3,941,118 2018-10-16 0    Premium*  
            Tscan Therapeutics, Inc. TCRX 10% Owner 2021-07-20 914,634 2021-07-20 1,400,789    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TCRX Tscan Therapeutics, Inc. 10% Owner   –       –       •   2021-07-20 4 B $15.00 $1,999,995 I/I 133,333 1,278,838 1.5 -
TCRX Tscan Therapeutics, Inc. 10% Owner   –       –       •   2021-07-20 4 A $0.00 $0 I/I 1,145,505 1,145,505 0 -
SLRX Salarius Pharmaceuticals,... 10% Owner   –       –       •   2018-10-16 4 S $0.92 $2,941,053 I/I (3,212,861) 0 0 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-11-08 4 B $7.31 $51,170 D/D 7,000 3,941,118 3.23 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-11-07 4 B $5.70 $50,559 D/D 8,870 3,934,118 3.23 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-23 4 B $11.28 $30,456 I/I 2,700 3,212,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-22 4 B $11.03 $31,987 I/I 2,900 3,210,161 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-21 4 B $11.07 $30,996 I/I 2,800 3,207,261 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-20 4 B $11.37 $34,110 I/I 3,000 3,204,461 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-17 4 B $10.98 $32,940 I/I 3,000 3,201,461 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-16 4 B $11.10 $32,190 I/I 2,900 3,198,461 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-15 4 B $11.24 $32,596 I/I 2,900 3,195,561 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-14 4 B $11.19 $33,570 I/I 3,000 3,192,661 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-13 4 B $11.90 $34,510 I/I 2,900 3,189,661 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-10 4 B $11.83 $35,490 I/I 3,000 3,186,761 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-09 4 B $12.04 $36,120 I/I 3,000 3,183,761 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-08 4 B $12.24 $35,496 I/I 2,900 3,180,761 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-07 4 B $12.26 $36,780 I/I 3,000 3,177,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-06 4 B $12.33 $36,990 I/I 3,000 3,174,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-03 4 B $12.79 $38,370 I/I 3,000 3,171,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-02 4 B $13.22 $66,100 I/I 5,000 3,168,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-06-01 4 B $12.76 $63,800 I/I 5,000 3,163,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-31 4 B $12.66 $63,300 I/I 5,000 3,158,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-27 4 B $12.68 $219,364 I/I 17,300 3,153,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-26 4 B $12.53 $204,239 I/I 16,300 3,136,561 2.64 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us